Print


ISIN and CFI Database for Non-Russian Financial Instruments that Meet the Requirements of Bank of Russia Regulation on Qualification

The Database contains ISIN and CFI codes allocated by authorized agencies in accordance with ISO 6166 and ISO 10962, and the CFI codes meet the requirements of paragraph 4.2 of the Directive of the Central Bank of the Russian Federation No. 4561-U dated October 3, 2017 "On the Procedure for the Qualification of Foreign Financial Instruments as Securities" (in the version of the Directive of Bank of Russia No. 4903-U dated 12.09.2018).

Information on non-Russian financial instruments is updated in real time as a result of processing clients' new requests relating to new instruments, and upon completion of NSD's daily monitoring of information on instruments already recorded in the Database.

Information on ISIN and CFI codes is provided by NSD to market participants solely for the purpose of qualification of non-Russian financial instruments as securities admitted for operations on the Russian market*.

 
Search key:
 
28541-28560 of 80001 results shown.
ISIN Issuer; Country Issue Description CFI Code Edition of IS0 10962 ISIN Status [?] Numbering Agency Information Source As of
US0774541066 BELDEN INC NEW; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US0781371069 BELL MICROPRODUCTS INC; US COM ESXXXX 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US078314AC52 BELLATRIX EXPL LTD; CA SR NT 144A DBFUGR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US07831C1036 BELLRING BRANDS INC NEW; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASB 2022-03-14
US0784541056 BELLE INTL HLDGS LTD; KY ADR EDSXFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US0787711029 BELLEROPHON THERAPEUTICS INC; US COM ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US0787713009 BELLEROPHON THERAPEUTICS INC; US COM NEW ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-01-10
US0794811077 BELLICUM PHARMACEUTICALS INC; US COM ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US0794814048 BELLICUM PHARMACEUTICALS INC; US COM NEW ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-01-10
US0798231009 BELLRING BRANDS INC; US CL A ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2022-04-01
US0798601029 BELLSOUTH CORP; US BLS GROUP COM ESXXXX 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US079860AE23 BELLSOUTH CORP; US DEB DBFSFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US079867AW73 BELLSOUTH TELECOMMUNICATIONS INC; US DEB DTD 06/04/1998 DBFUGR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US0805551050 BELO CORP; US COM SER A ESXXXX 2015 New Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US0814371052 BEMIS CO INC; US COM ESVUFR 2015 New Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US081437AJ44 BEMIS CO INC; US NT DBFUGR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US08160E2072 BENCHMARK BANKSHARES INC; US COM NEW ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US08160H1014 BENCHMARK ELECTRS INC; US COM ESXXXX 2015 New Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US08171T1025 BENEFICIAL BANCORP INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US08172LV549 BENEFICIAL CORP MEDIUM TERM NTS-BOOK ENTRY; US TRANCHE # TR 00732 DTD 09/01/93 DTXXXX 2015 New Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26

* NSD does not make any representation or warranty as to the completeness or reliability of the information contained herein, nor does it make any warranty regarding its consistency with the purposes for which the information is used, including but not limited to, commercial purposes. The information published on this website is not to be construed as an offer to effect any deal with financial instruments, and should not be used for commercial or other purposes; nor does it represent an offer from NSD to render any services; nor does it make any warranty or representation of reliability of certain financial instruments or persons (including but not limited to, issuers, securities market participants, etc.).


For further information, please refer to NSD’s experts.

Printed version

Print